Brain aneurysms do run in families, and the evidence for a genetic component is strong enough that medical guidelines now recommend screening certain relatives of affected patients. About 1 to 3 percent of the general population has an intracranial aneurysm, but that figure roughly quadruples when a first-degree relative has one. The genetics behind this risk are complex, involving both rare inherited syndromes and a patchwork of common gene variants that each contribute a small amount of susceptibility.
How Much Does Family History Raise the Risk
The most consistent finding across studies is that having even one first-degree relative (a parent, sibling, or child) with a brain aneurysm meaningfully increases your own odds. A systematic review of screening studies found that people with at least one affected first-degree relative had an average aneurysm prevalence of about 4.8 percent, and those with additional risk factors saw rates as high as 19 percent.1PubMed. Screening for Intracranial Aneurysms in Individuals with a Positive First-Degree Family History: A Systematic Review When two or more first-degree relatives are affected, the average prevalence jumps to around 13 percent, which is roughly four times the general population rate.1PubMed. Screening for Intracranial Aneurysms in Individuals with a Positive First-Degree Family History: A Systematic Review
The familial clustering does not appear to vary dramatically by ethnicity. A study comparing rates of family history among Caucasian, African-American, and Hispanic patients with aneurysms found strikingly similar numbers: about 19 to 22 percent of patients across all three groups reported at least one affected family member.2PubMed. Incidence of familial intracranial aneurysms in 200 patients: comparison among Caucasian, African-American, and Hispanic populations This consistency suggests the genetic underpinnings are not confined to any single ancestry group. That said, certain populations do show higher overall aneurysm rates. The French-Canadian population, for example, has both a higher incidence and more frequent familial clustering, likely driven by a founder effect where a small number of original settlers carried risk variants that became concentrated over generations.3PubMed Central. Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysm in the French-Canadian population
Inherited Syndromes That Carry Higher Aneurysm Risk
Some people carry aneurysm risk not as a subtle background probability but as part of a recognized genetic syndrome. These conditions are relatively rare individually, but anyone diagnosed with one should be aware of the vascular implications.
Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly discussed. It affects roughly 1 in 1,000 people worldwide and is best known for causing fluid-filled cysts on the kidneys, but it also weakens blood vessel walls throughout the body.4PubMed Central. Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms? The two genes most commonly responsible, PKD1 and PKD2, produce proteins involved in maintaining the structural integrity of cells, including those lining blood vessels. Research suggests that variants in PKD1 may carry a stronger association with intracranial aneurysms than variants in PKD2.5Mayo Clinic Proceedings. Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management Because of this elevated risk, ADPKD patients are widely considered candidates for aneurysm screening even without a family history of brain hemorrhage.6PubMed Central. Preventive screening for intracranial aneurysms
Loeys-Dietz syndrome is rarer and primarily affects connective tissue. Multiple gene variants that cause this syndrome converge on a single signaling pathway involved in how the body builds and maintains the elastic fibers in artery walls. The resulting dysfunction leads to weaker vessel walls prone to dilation and aneurysm formation throughout the body, including in the brain.7Journal of Neurosurgery. Natural history and growth rate of intracranial aneurysms in Loeys-Dietz syndrome: implications for treatment Other connective tissue disorders, including vascular Ehlers-Danlos syndrome and Marfan syndrome, also predispose to aneurysms, though the intracranial risk profile differs somewhat between them.
When There Is No Syndrome but the Family Pattern Is Clear
Most people with a family history of brain aneurysms do not have one of the syndromes described above. Their risk is driven instead by a combination of many common genetic variants, each nudging susceptibility up by a small amount. Researchers have made real progress in identifying these variants over the past decade.
The largest genome-wide association study on intracranial aneurysms to date pooled data from more than 10,000 cases and over 300,000 controls of European and East Asian ancestry. It identified 17 locations in the genome associated with aneurysm risk, 11 of which had not been previously linked to the condition.8PubMed Central. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors That study also found genetic overlap between aneurysm susceptibility and known clinical risk factors like high blood pressure, suggesting the same genes may partly drive both the tendency toward hypertension and the tendency toward vessel wall weakness.
Fine-mapping studies have since drilled deeper into these regions. One analysis identified 13 specific genetic variants with high confidence of being causal rather than merely nearby markers. Among these, a variant in the gene ARHGAP32 stood out as having the strongest individual association with increased risk, and it alone accounted for an estimated 14 percent of the heritable variation in aneurysm susceptibility.9Scientific Reports. Fine-mapping of intracranial aneurysm susceptibility based on a genome-wide association study Other variants in genes like GBA, TCF24, and OLFML2A were linked to amino acid changes in the proteins they encode, offering possible mechanistic explanations for how these common variants might weaken blood vessel walls.
Work in Japanese populations has contributed additional pieces to the puzzle. One study confirmed the role of a variant near the EDNRA gene on chromosome 4, which encodes a receptor involved in blood vessel constriction and remodeling, and validated a previously identified risk locus on chromosome 9.10Human Molecular Genetics. Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA The chromosome 9 region, known as 9p21, is one of the most replicated genetic findings in vascular disease research; it is also linked to coronary artery disease and aortic aneurysms, hinting that certain vessel-weakening pathways are shared across different types of vascular events.
How Smoking and High Blood Pressure Amplify Genetic Risk
Genes are not the only factor, and the interaction between inherited risk and modifiable risk factors is one of the most practically relevant findings in aneurysm research. A study comparing people with and without a family history of aneurysmal subarachnoid hemorrhage (the life-threatening rupture of an aneurysm) found that genetic predisposition and smoking together create a risk far greater than either one alone. Nonsmokers with a family history had roughly two and a half times the risk of subarachnoid hemorrhage compared to nonsmokers without a family history. Smokers without a family history had about three times the risk. But smokers with a positive family history had roughly six times the risk, which is more than you would expect from simply adding the two factors together.11PubMed Central. Smoking and family history and risk of aneurysmal subarachnoid hemorrhage The statistical analysis confirmed this was a true synergistic interaction, not just two independent risks stacking up.
Blood pressure control matters after an aneurysm is found and treated, too. A large population-based study tracking patients after aneurysm treatment found that uncontrolled high blood pressure was associated with a significantly increased risk of poor outcomes. Each 10-point rise in systolic blood pressure raised that risk by about 16 percent, and each 10-point rise in diastolic blood pressure raised it by about 32 percent.12PubMed Central. Association between longitudinal blood pressure and prognosis after treatment of cerebral aneurysm: A nationwide population-based cohort study For someone with a genetic predisposition, this evidence argues that controlling blood pressure and avoiding smoking are among the most powerful ways to reduce their absolute risk.
How Familial Aneurysms Behave Differently
Aneurysms that arise in a familial context are not identical to those found in patients with no family history. Research comparing the two groups has identified several distinct patterns. Familial aneurysms tend to rupture at a younger age and at a smaller size than sporadic ones. They also show a different distribution across the brain’s arteries: they are more commonly found at the middle cerebral artery and less commonly at the anterior communicating artery, which is one of the most frequent locations for sporadic aneurysms.13PubMed Central. Familial intracranial aneurysms
The tendency to rupture at smaller sizes is clinically significant. Standard guidelines for managing unruptured aneurysms rely heavily on size thresholds to decide whether to treat or watch. If familial aneurysms are more rupture-prone at sizes that would typically be considered low-risk, that information should factor into the decision-making process. This is one reason many neurosurgeons approach familial cases with a lower threshold for intervention.
Who Should Get Screened and How Often
Screening for brain aneurysms typically involves magnetic resonance angiography, a noninvasive imaging test that does not require radiation or injecting contrast dye into an artery. The question is who benefits enough to justify the screening, given that finding an aneurysm also carries costs: anxiety, the need for follow-up imaging, and sometimes unnecessary treatment of aneurysms that never would have ruptured.
The evidence supports screening for two groups most clearly. First, people with two or more first-degree relatives who have had aneurysmal subarachnoid hemorrhage. Second, patients with ADPKD.6PubMed Central. Preventive screening for intracranial aneurysms For these groups, the probability of finding an aneurysm is high enough that the benefits of early detection outweigh the downsides of screening. Some experts advocate screening people with even one affected first-degree relative, especially if other risk factors like smoking or hypertension are present, but the evidence base for this broader approach is less settled.
Screening is not a one-time event. Among individuals with a family history who initially screen negative, about 7 percent develop aneurysms that are found on subsequent screens.14Neurosurgical Focus. The case for family screening for intracranial aneurysms Aneurysms can also form and rupture within a five-year window, so the general recommendation for high-risk individuals is to repeat screening roughly every five years.14Neurosurgical Focus. The case for family screening for intracranial aneurysms One older modeling study used a 10-year interval, but most current guidance leans toward the shorter window.15PubMed. Should we screen for familial intracranial aneurysm?
Genetic Risk Scores and the Future of Prediction
As researchers identify more genetic variants associated with aneurysms, one practical question is whether these can be combined into a single score that predicts who is most at risk. Early work on a combined genetic risk score has shown some promise. In one study, each standard-deviation increase in a person’s genetic risk score was associated with a 34 percent increase in the hazard of subarachnoid hemorrhage. Adding the score on top of traditional clinical risk factors (like age, sex, blood pressure, and smoking status) modestly improved prediction of hemorrhage, nudging the overall accuracy from 0.63 to 0.65.16PubMed Central. Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity
That improvement might sound tiny, but there are reasons to be cautiously interested. The same score was also statistically linked to the age at which hemorrhage occurred and to the location of the aneurysm within the brain.16PubMed Central. Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity If genetic scores can eventually help distinguish higher-risk from lower-risk aneurysms, not just higher-risk people, that would change how doctors decide which small aneurysms to treat versus watch. The scores are not ready for routine clinical use yet, but they represent the direction the field is heading.
The Psychological Weight of Knowing
A conversation about genetic risk and screening would be incomplete without acknowledging what happens when someone actually receives an aneurysm diagnosis. Even when the aneurysm is unruptured and small, the knowledge alone can be psychologically disruptive. In one study, more than half of patients diagnosed with a small unruptured aneurysm scored high enough on standard mental health scales to indicate at least mild anxiety or depression.17PubMed Central. Psychological and Functional Impact of a Small Unruptured Intracranial Aneurysm Diagnosis: A Mixed-Methods Evaluation of the Patient Journey
A larger analysis compared mental health diagnoses in the year before and the year after an unruptured aneurysm was discovered. Rates of depression rose by about 4.6 percentage points, anxiety by 4.5 points, and insomnia by 3.8 points. The median time to a new depression or anxiety diagnosis after discovery was just 53 days.18medRxiv. The Psychological Footprint of Unruptured Intracranial Aneurysm Discovery Researchers who have reviewed these outcomes consistently argue that psychological follow-up should be a standard part of care for anyone diagnosed with an intracranial aneurysm, not an afterthought.19PubMed Central. Psychological and cognitive outcomes in patients with unruptured intracranial aneurysms and aneurysmal subarachnoid haemorrhage: a multidimensional assessment
This psychological dimension is especially relevant for people considering screening based on family history. Screening can find treatable problems early, but it can also reveal small aneurysms that may never pose a serious threat, leaving patients living with a diagnosis that weighs on them for years. This tradeoff is worth discussing openly with a doctor before beginning the screening process, particularly when the family risk profile falls in the gray area (one affected relative, no other risk factors) where the benefit of screening is less certain.
What a Family History Conversation With Your Doctor Should Cover
If a close blood relative has been diagnosed with a brain aneurysm or has suffered a subarachnoid hemorrhage, there are a few specific things worth discussing at your next medical visit. The distinction between a relative who had an aneurysm found incidentally (say, during an MRI for something else) and one who had a rupture matters, because rupture in the family is a stronger predictor of your own rupture risk. The number of affected relatives matters: two or more tips the balance decisively toward screening, while one affected relative puts you in a murkier zone where other risk factors help determine the best course.
Your own modifiable risk factors should be part of the conversation. Given the evidence of synergistic interaction between genetics and smoking, quitting smoking is arguably the single highest-impact action for someone with a family history. Keeping blood pressure well controlled is a close second. These steps do not eliminate genetic risk, but they can substantially reduce the absolute probability that a genetic predisposition will lead to a catastrophic event.
If you have ADPKD, Loeys-Dietz syndrome, or another connective tissue disorder known to be associated with aneurysms, screening is generally recommended regardless of whether anyone in your family has had a brain hemorrhage. The syndrome itself is the indication. For everyone else, the decision to screen is a judgment call shaped by how many relatives are affected, how old they were when their aneurysms were found or ruptured, and what other vascular risk factors you carry.